MENLO PARK, Calif.,
March 5, 2018 /PRNewswire/ --
BioPharmX Corporation (NYSE American: BPMX), a specialty
pharmaceutical company developing dermatology products, today
announces that it will present its updated corporate presentation
at the 30th Annual ROTH Conference in Orange County, Calif., where it will also be
webcast live.
Anja Krammer, president and
co-founder of BioPharmX, will provide an updated overview of the
company at the conference on Monday, March
12, at 4:30 p.m. PDT in Blue –
Salon 2 at The Ritz-Carlton hotel in Dana
Point.
The live webcast will be available at
http://wsw.com/webcast/roth32/bpmx/ and a replay will be accessible
for 90 days following the presentation.
The annual ROTH Conference, hosted by ROTH Capital Partners
March 11-13, gathers close to 550
companies and over 4,700 attendees, featuring presentations from
public and private companies in a variety of sectors including
healthcare.
Inducement Grant
The compensation committee of
BioPharmX Corporation's board of directors awarded a non-qualified
stock option to purchase 400,000 shares of BioPharmX Corporation's
common stock at an exercise price of $0.19 to an employee. The stock option will vest
at the rate of 25% of the shares on the first anniversary of the
commencement of employment and then one forty-eighth (1/48) of the
shares monthly thereafter, subject to the employee's continued
service with BioPharmX. The stock option grant was granted as an
inducement material to the employee's employment in accordance with
Section 711(a) of the NYSE American Company guide.
About BioPharmX® Corporation
BioPharmX
Corporation (NYSE American: BPMX) is a Silicon Valley-based
specialty pharmaceutical company, which seeks to provide products
through proprietary platform technologies for prescription,
over-the-counter (OTC), and supplement applications in the health
and wellness markets, including dermatology and women's health. To
learn more about BioPharmX, visit www.BioPharmX.com.
BioPharmX is a registered trademark of BioPharmX, Inc.
View original content with
multimedia:http://www.prnewswire.com/news-releases/biopharmx-to-present-at-30th-annual-roth-conference-300607629.html
SOURCE BioPharmX Corporation